1. Market Research
  2. > Pharmaceutical Market Trends
  3. > India Pharmaceuticals and Healthcare Report Q2 2016

India Pharmaceuticals and Healthcare Report Q2 2016

  • February 2016
  • -
  • Business Monitor International
  • -
  • 112 pages

Includes 3 FREE quarterly updates
Table Of Contents

India Pharmaceuticals and Healthcare Report Q2 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (India 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (India 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (India 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (India 2012-2020) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (India 2012-2020) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (India 2012-2020) 19
Patented Drug Market Forecast 20
Table: Selected Patent Developments Affecting Drugmakers 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (India 2012-2020) 23
Generic Drug Market Forecast 24
Table: Generic Drug Market Indicators, Historical Data And Forecasts (India 2012-2020) 25
OTC Medicine Market Forecast 26
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (India 2012-2020) 27
Pharmaceutical Trade Forecast 28
Table: Pharmaceutical Trade Data And Forecasts (India 2014-2020) 29
Table: Pharmaceutical Trade Data And Forecasts local currency (India 2014-2020) 30
Industry Risk Reward Index 31
Asia Pacific Risk/Reward Index 31
India Risk/Reward Index 37
Rewards 37
Risks 37
Regulatory Review 38
Intellectual Property Issues 42
Table: History Of The Indian Patent System 43
Table: A Series Of Setbacks For Innovative Pharmaceutical Firms 44
Pricing Regime 48
Market Overview 53
Healthcare Sector 53
Table: Healthcare Resources (India 2010-2015) 56
Table: Healthcare Personnel (India 2010-2015) 56
Table: Healthcare Activity (India 2010-2015) 57
Clinical Trials 59
Epidemiology 61
Table: Estimated Number Of New Cases Of Cancer In India 63
Competitive Landscape 64
Research-Based Industry 64
Table: Ordinary Members Of OPPI 64
Table: Multinational Market Activity 65
Generic Drug Industry 66
Pharmaceutical Distribution 66
Pharmaceutical Retail Sector 68
Company Profile 69
Aurobindo Pharmaceutical 69
Cipla 72
Dr Reddy's Laboratories 76
GlaxoSmithKline 80
Merck and Co 84
Novartis 87
Pfizer 91
Sanofi India 96
Sun Pharmaceutical 99
Demographic Forecast 101
Table: Population Headline Indicators (India 1990-2025) 102
Table: Key Population Ratios (India 1990-2025) 102
Table: Urban/Rural Population and Life Expectancy (India 1990-2025) 103
Table: Population By Age Group (India 1990-2025) 103
Table: Population By Age Group % (India 1990-2025) 104
Glossary 106
Methodology 108
Pharmaceutical Expenditure Forecast Model 108
Healthcare Expenditure Forecast Model 108
Notes On Methodology 109
Risk/Reward Index Methodology 110
Index Overview 111
Table: Pharmaceutical Risk/Reward Index Indicators 111
Indicator Weightings 112

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.